IN2014MU01194A - - Google Patents

Info

Publication number
IN2014MU01194A
IN2014MU01194A IN1194MU2014A IN2014MU01194A IN 2014MU01194 A IN2014MU01194 A IN 2014MU01194A IN 1194MU2014 A IN1194MU2014 A IN 1194MU2014A IN 2014MU01194 A IN2014MU01194 A IN 2014MU01194A
Authority
IN
India
Prior art keywords
acceptable derivative
pharmaceutical
sulbactam
cefepime
stereoisomer
Prior art date
Application number
Other languages
English (en)
Inventor
Sachin Bhagwat
Mahesh Vithalbhai Patel
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to KR1020167027684A priority Critical patent/KR20160130824A/ko
Priority to US15/300,113 priority patent/US20170151221A1/en
Priority to EP15706531.9A priority patent/EP3125887A1/en
Priority to IN1194MU2014 priority patent/IN2014MU01194A/en
Priority to MX2016012646A priority patent/MX2016012646A/es
Priority to PCT/IB2015/050268 priority patent/WO2015150926A1/en
Priority to CN201580017231.6A priority patent/CN106900171A/zh
Priority to JP2016558575A priority patent/JP2017508769A/ja
Priority to BR112016022439A priority patent/BR112016022439A2/pt
Publication of IN2014MU01194A publication Critical patent/IN2014MU01194A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IN1194MU2014 2014-03-29 2015-01-14 IN2014MU01194A (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1020167027684A KR20160130824A (ko) 2014-03-29 2015-01-14 세페파임 또는 술박탐을 포함하는 제약학적 조성물
US15/300,113 US20170151221A1 (en) 2014-03-29 2015-01-14 Pharmaceutical compositions comprising cefepime or sulbactam
EP15706531.9A EP3125887A1 (en) 2014-03-29 2015-01-14 Pharmaceutical compositions comprising cefepime or sulbactam
IN1194MU2014 IN2014MU01194A (es) 2014-03-29 2015-01-14
MX2016012646A MX2016012646A (es) 2014-03-29 2015-01-14 Composiciones farmaceuticas que comprenden agentes antibacterianos.
PCT/IB2015/050268 WO2015150926A1 (en) 2014-03-29 2015-01-14 Pharmaceutical compositions comprising cefepime or sulbactam
CN201580017231.6A CN106900171A (zh) 2014-03-29 2015-01-14 包含头孢吡肟或舒巴坦的药物组合物
JP2016558575A JP2017508769A (ja) 2014-03-29 2015-01-14 セフェピムまたはスルバクタムを含む医薬組成物
BR112016022439A BR112016022439A2 (pt) 2014-03-29 2015-01-14 Composições farmacêuticas que compreendem cefepima ou sulbactama

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1194MU2014 IN2014MU01194A (es) 2014-03-29 2015-01-14

Publications (1)

Publication Number Publication Date
IN2014MU01194A true IN2014MU01194A (es) 2015-10-02

Family

ID=54239460

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1194MU2014 IN2014MU01194A (es) 2014-03-29 2015-01-14

Country Status (9)

Country Link
US (1) US20170151221A1 (es)
EP (1) EP3125887A1 (es)
JP (1) JP2017508769A (es)
KR (1) KR20160130824A (es)
CN (1) CN106900171A (es)
BR (1) BR112016022439A2 (es)
IN (1) IN2014MU01194A (es)
MX (1) MX2016012646A (es)
WO (1) WO2015150926A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230365561A1 (en) * 2020-09-01 2023-11-16 Ningxia Academy Of Agricul Ture And Forestry Sciences Beta-lactamase inhibitors and their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE476981T1 (de) * 2004-12-02 2010-08-15 Venus Remedies Ltd Zusammensetzungen zur bekämpfung von beta- lactamase-vermittelter antibiotischer resistenz mittels beta-lactamase-hemmern für injektionen
RU2593363C2 (ru) * 2011-05-28 2016-08-10 Вокхардт Лимитед Композиции, включающие антибактериальное средство и тазобактам
WO2013014497A1 (en) * 2011-07-26 2013-01-31 Wockhardt Limited Pharmaceutical compositions comprising beta-lactam antibiotic, sulbactam and beta-lactamase inhibitor
BR112013032711A2 (pt) * 2011-07-26 2017-01-17 Wockhardt Ltd composições farmacêuticas compreendendo sulbactam e inibidor de beta-lactamase
ES2603198T3 (es) * 2011-08-27 2017-02-24 Wockhardt Limited Derivados de 1,6-diazabiciclo [3,2,1]octan-7-ona y su uso en el tratamiento de infecciones bacterianas
US8796257B2 (en) * 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
ES2672100T3 (es) * 2012-08-25 2018-06-12 Wockhardt Limited Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona y su uso en el tratamiento de infecciones bacterianas
WO2014141132A1 (en) * 2013-03-14 2014-09-18 Naeja Pharmaceutical Inc. NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS

Also Published As

Publication number Publication date
JP2017508769A (ja) 2017-03-30
KR20160130824A (ko) 2016-11-14
BR112016022439A2 (pt) 2017-08-15
CN106900171A (zh) 2017-06-27
MX2016012646A (es) 2016-10-28
WO2015150926A1 (en) 2015-10-08
EP3125887A1 (en) 2017-02-08
US20170151221A1 (en) 2017-06-01

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
EP3565550A4 (en) PHARMACEUTICAL COMPOSITIONS WITH MELOXICAM
TW201613911A (en) Heterocyclic compounds and uses thereof
PH12016502255A1 (en) Combination
JOP20200122B1 (ar) مركبات مفيدة لتثبيط cdk7
PH12018500061A1 (en) Oxysterols and methods of use thereof
MX2018002986A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y sus usos.
EP3621621A4 (en) PHARMACEUTICAL COMPOSITIONS WITH MELOXICAM
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
MX2016013431A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.
MX2018014813A (es) Composiciones antibacterianas.
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
PH12017502319A1 (en) Injectable pharmaceutical formulations of lefamulin
NZ739518A (en) Compounds useful for inhibiting ror-gamma-t
TW201613898A (en) Benzofuran analogue as NS4B inhibitor
IN2014MU00859A (es)
IN2013MU03421A (es)
IN2013MU03704A (es)
IN2013MU03422A (es)
IN2013MU03309A (es)
IN2014MU01194A (es)
IN2013MU03308A (es)
MX2018010652A (es) Composiciones farmaceuticas.
MX2016013428A (es) Composiciones farmaceuticas que comprenden agentes antibacterianos.